Roivant Sciences (ROIV)CEO sold ~$8.45M

~$8.45M

Approx. value · 290K sh @ $29.16

16.7M

Holds after · shares reported

Traded

Apr 16, 2026

Filed

Apr 21, 2026

The story around this disclosure

Every dated public record OQRO holds about the company from 60 days before to 120 days after, oldest first. It shows what was going on; none of it is a stated reason for the trade.

1. Feb 13, 2026InsiderCEO sold ~$5.3M of ROIV shares in the open market
2. Feb 19, 2026InsiderChair sold ~$38.4M of ROIV shares in the open market
3. Feb 20, 2026InsiderChair sold ~$27.5M of ROIV shares in the open market
4. Feb 23, 2026InsiderChair sold ~$16.2M of ROIV shares in the open market
5. Mar 3, 2026Company filing · Form 8-K · Material agreement, Reg FDSigned an important agreement, and shared information with investors (and 1 more item)
6. Mar 3, 2026Company filing · Form 8-K · Material agreementSigned an important agreement
7. Mar 16, 2026InsiderDirector sold ~$1.2M of ROIV shares in the open market
8. Mar 17, 2026InsiderCEO sold ~$5.65M of ROIV shares in the open market
9. Mar 26, 2026Insider · 7 days before resultsDirector sold ~$1.92M of ROIV shares in the open market
10. Apr 2, 2026Company filing · Form 8-K · Results, Reg FDReported its results, and shared information with investors
11. Apr 8, 2026InsiderOfficer sold ~$384K of ROIV shares in the open market
12. Apr 16, 2026 · this disclosureInsiderCEO sold ~$8.45M of ROIV shares in the open market

What came next

1. Apr 20, 2026InsiderCEO sold ~$5.92M of ROIV shares in the open market
2. May 20, 2026Company filing · Form 8-K · ResultsReported its results
3. May 22, 2026InsiderCEO sold ~$6.05M of ROIV shares in the open market
4. Jun 24, 2026Insider · 1 personInsiders: 2 sales (~$6.6M)
5. Jun 25, 2026InsiderDirector sold ~$17.1M of ROIV shares in the open market
6. Jun 26, 2026Insider · 4 peopleInsiders: 7 sales (~$80.9M)
7. Jun 29, 2026Insider · 4 peopleInsiders: 8 sales (~$83.5M)
8. Jun 30, 2026Insider · 4 peopleInsiders: 5 sales (~$8.7M)
9. Jul 27, 2026InsiderCEO sold ~$6.99M of ROIV shares in the open market
10. Aug 6, 2026Company filing · Form 8-K · ResultsReported its results

How to read SEC Form 4

Form 4 is the filing that officers, directors and owners of more than 10% of a US-listed company must send to the SEC within two business days after they buy, sell or otherwise change their holding of the company's stock.

Full guide: What is an SEC Form 4?

What else is on file for Roivant Sciences

For Roivant Sciences, OQRO holds 18 insider filings (SEC Form 4 or Form 144) and 10 fund holdings reports (13F) dated in the last 90 days.

These are records OQRO holds, counted by their date, not a measure of how much trading took place. Routine paperwork such as option exercises and tax withholding is left out. Everything for the company is on its ROIV page.

Other recent filings by Matthew Gline, CEO

• SEC Form 4 at Roivant Sciences (ROIV)Dec 18, 2025
• SEC Form 4 at Roivant Sciences (ROIV)Dec 18, 2025
• SEC Form 4 at Roivant Sciences (ROIV)Dec 18, 2025
• SEC Form 4 at Roivant Sciences (ROIV)Sep 18, 2025

The full history of Matthew Gline, CEO is on the profile page.

How this filing works

• SEC Form 4
• Open-market purchase
• Rule 10b5-1 trading plans

Other disclosures at Roivant Sciences

• SEC Form 4Oct 6, 2026
• SEC Form 4Oct 6, 2026
• SEC Form 4Oct 3, 2026
• SEC Form 4Sep 18, 2026
• SEC Form 4Sep 18, 2026
• SEC Form 4Sep 18, 2026

Everything OQRO holds on this company is on its ROIV page.